In a 27-year-old woman with a mild, persistent elevation of liver enzymes for two years, what is the next step in the workup?

Next Workup Step for Persistent Mild Liver Enzyme Elevation

In a 27-year-old woman with mild liver enzyme elevation persisting for two years, the next step is to perform a comprehensive liver aetiology screen including: abdominal ultrasound, hepatitis B surface antigen, hepatitis C antibody (with PCR if positive), anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody, serum immunoglobulins, and simultaneous serum ferritin with transferrin saturation. 1

Rationale for This Approach

The two-year duration of elevation qualifies as chronic (>6 months), which warrants a complete diagnostic evaluation rather than continued observation 2. The most recent guidelines from 2018 provide a clear algorithmic approach for this exact scenario 1.

The Standard Core Panel Should Include:

• Abdominal ultrasound – to identify fatty liver (present in ~40% of cases with abnormal enzymes), structural abnormalities, or biliary pathology
• Viral hepatitis screening – HBsAg and HCV antibody (with reflex PCR if positive)
• Autoimmune markers – anti-mitochondrial antibody (for primary biliary cholangitis), anti-smooth muscle antibody and antinuclear antibody (for autoimmune hepatitis), serum immunoglobulins
• Iron studies – simultaneous ferritin and transferrin saturation to screen for hereditary hemochromatosis (transferrin saturation >45% is significant) 1

Important Clinical Context to Obtain:

Before ordering tests, assess specific risk factors that guide interpretation:

• Metabolic syndrome features – BMI, waist circumference, blood pressure, fasting glucose/HbA1c, lipid panel (NAFLD is the most common cause) 3
• Alcohol intake – quantify in units per week using structured tools like AUDIT-C 1
• Medication history – including over-the-counter drugs, supplements, and herbal products 2
• Family history – particularly autoimmune diseases, inflammatory bowel disease (raises PSC suspicion), or hereditary liver conditions 1
• Country of origin – strongest predictor of viral hepatitis risk 1

Key Evidence-Based Insights

The BALLETS study provides crucial context: among 1,290 adults with abnormal liver tests in primary care, only 1.3% had a specific liver disease requiring immediate treatment (viral hepatitis or hemochromatosis), while <5% had any specific liver disease 1. However, nearly 40% had fatty liver on ultrasound, with obesity being the strongest predictor 1.

Pattern Recognition Matters

While the question states "mild elevation," determining the pattern of injury is critical:

• Hepatocellular pattern (ALT/AST predominant) – suggests NAFLD, alcohol, viral hepatitis, autoimmune hepatitis, hemochromatosis, Wilson's disease (though rare at age 27)
• Cholestatic pattern (alkaline phosphatase/GGT predominant) – suggests biliary pathology, primary biliary cholangitis, or PSC 4, 5

Common Pitfalls to Avoid

1. Don't use male reference ranges – sex-specific upper limits of normal are essential; female ALT ULN is typically 35 U/L versus 57 U/L for males 6

2. Don't dismiss isolated elevated ferritin – this commonly reflects dysmetabolic iron overload in NAFLD/alcohol excess, not hemochromatosis; transferrin saturation >45% is the key discriminator 1

3. Don't order the extended panel initially – reserve alpha-1-antitrypsin, ceruloplasmin, and additional autoantibodies for cases where the core panel is unrevealing 1

4. Don't rush to liver biopsy – in young patients with mild elevation and no cirrhosis features, biopsy has limited diagnostic yield and can be safely deferred 7

After Initial Testing

• If core panel identifies a specific disease (positive HBsAg, HCV, autoimmune markers with elevated IgG, or hemochromatosis with transferrin saturation >45%) → refer to hepatology 1

• If testing suggests NAFLD/ARLD (fatty liver on ultrasound, metabolic syndrome features, negative viral/autoimmune workup) → initiate lifestyle modification and reassess in primary care; most will not require specialist referral 1

• If core panel is completely unrevealing → consider extended panel testing or specialist consultation, particularly given the chronic nature (2 years) 2, 1

The algorithmic approach prioritizes identifying treatable causes (viral hepatitis, autoimmune disease, hemochromatosis) while recognizing that the majority will have metabolic dysfunction-associated steatotic liver disease requiring lifestyle intervention rather than specialist care 1, 3.